Food and Drug Administration Modernization Act
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:abbreviation |
gptkb:FDAMA
|
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:containsProvision |
regulation of medical devices
dissemination of information on off-label uses expanded access to investigational drugs fast track drug approval regulation of pharmacy compounding |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:dateEnacted |
1997-11-21
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| https://www.w3.org/2000/01/rdf-schema#label |
Food and Drug Administration Modernization Act
|
| gptkbp:publicLawNumber |
gptkb:Public_Law_105-115
|
| gptkbp:purpose |
to reform regulation of food, drugs, devices, and biological products
|
| gptkbp:repealedBy |
Section 503A (compounding) declared unconstitutional in part
|
| gptkbp:signedBy |
gptkb:Bill_Clinton
|
| gptkbp:bfsParent |
gptkb:fast_track_designation
|
| gptkbp:bfsLayer |
5
|